Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
11.35
+0.35 (3.18%)
At close: Feb 13, 2026, 4:00 PM EST
11.36
+0.01 (0.09%)
After-hours: Feb 13, 2026, 7:16 PM EST
DAWN Market Cap
DAWN has a market cap or net worth of $1.17 billion as of February 13, 2026. Its market cap has decreased by -11.18% in one year.
Market Cap
1.17B
Enterprise Value
716.68M
1-Year Change
-11.18%
Ranking
Category
Stock Price
$11.35
Market Cap Chart
Since the IPO on May 27, 2021, DAWN's market cap has increased from $965.40M to $1.17B, an increase of 20.71%. That is a compound annual growth rate of 4.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.13B | 18.03% |
| Dec 31, 2025 | 956.94M | -25.11% |
| Dec 31, 2024 | 1.28B | 0.54% |
| Dec 29, 2023 | 1.27B | -19.71% |
| Dec 30, 2022 | 1.58B | 51.68% |
| Dec 31, 2021 | 1.04B | 8.09% |
| May 27, 2021 | 965.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Capricor Therapeutics | 1.22B |
| Inhibrx Biosciences | 1.19B |
| Inventiva | 1.19B |
| Nanobiotix | 1.18B |
| Septerna | 1.15B |
| Xeris Biopharma Holdings | 1.15B |
| Compass Therapeutics | 1.13B |
| MoonLake Immunotherapeutics | 1.11B |